Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Prostatic Neoplasms 6 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Liver Neoplasms 3 Uterine Cervical Neoplasms 2 Tongue Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Liver Cirrhosis 2 Kidney Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Urologic Neoplasms 1 Urethral Neoplasms 1 Thoracic Neoplasms 1 Testicular Neoplasms 1 Solid Tumor 1 Renal Colic 1 Rectal Neoplasms 1 Pregnancy, Ectopic 1 Pneumonia 1 Pleural Effusion 1 Phlebitis 1 Penile Neoplasms 1 Mesothelioma 1 Melanoma 1 Margins of Excision 1 Lymphoma, Primary Effusion 1

Interventions

Carboplatin 339 Cisplatin 238 Paclitaxel 203 Radiotherapy 194 Pemetrexed 187 Docetaxel 169 Gemcitabine 157 pembrolizumab 140 Erlotinib Hydrochloride 107 Etoposide 98 Magnetic Resonance Spectroscopy 92 Bevacizumab 91 Specimen Handling 76 Nivolumab 73 Radiosurgery 71 durvalumab 69 Vinorelbine 54 osimertinib 53 Gefitinib 49 Drug Therapy 49 Irinotecan 42 atezolizumab 41 Topotecan 39 Radiation 39 Biopsy 39 Cyclophosphamide 38 Standard of Care 37 Cetuximab 35 Blood Specimen Collection 33 Taxes 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lung Neoplasms × Ultrasonography × Clear all

NCT05321615 2023-10-25

Palpator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Unknown

Lung Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡